Skip to main content
. 2021 Oct 23;94(3):823–828. doi: 10.1002/jmv.27380

Figure 1.

Figure 1

Schematic representation of SARS‐CoV‐2‐driven signaling pathways and potential drug targets. Images reproduced from Catanzaro et al. 61  This article is licensed under a creative commons attribution 4.0 international license. http://creativecommons.org/licenses/by/4.0/. GM‐CSF, granulocyte‐macrophage colony‐stimulating factor; IL‐6, interleukin 6; JAK, Janus kinase; NF‐κB, nuclear factor‐κB; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; STAT, signal transducer and activator of transcription; TNF‐α, tumor necrosis factor‐α